Our drug R&D is supported by scientific research published by the Akero team, our collaborators, and by external experts.
Feb 2024 | From Akero Therapeutics
Decreases in liver cT1 accurately reflect histological improvement induced by therapies in MASH: a multi-centre pooled cohort analysis

